1. Home
  2. BCAX vs BLFS Comparison

BCAX vs BLFS Comparison

Compare BCAX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • BLFS
  • Stock Information
  • Founded
  • BCAX 2018
  • BLFS 1987
  • Country
  • BCAX United States
  • BLFS United States
  • Employees
  • BCAX N/A
  • BLFS N/A
  • Industry
  • BCAX
  • BLFS Medical/Dental Instruments
  • Sector
  • BCAX
  • BLFS Health Care
  • Exchange
  • BCAX NYSE
  • BLFS Nasdaq
  • Market Cap
  • BCAX 1.0B
  • BLFS 1.2B
  • IPO Year
  • BCAX 2024
  • BLFS 1989
  • Fundamental
  • Price
  • BCAX $16.34
  • BLFS $25.39
  • Analyst Decision
  • BCAX Strong Buy
  • BLFS Strong Buy
  • Analyst Count
  • BCAX 5
  • BLFS 7
  • Target Price
  • BCAX $41.33
  • BLFS $28.29
  • AVG Volume (30 Days)
  • BCAX 347.7K
  • BLFS 385.0K
  • Earning Date
  • BCAX 02-16-2025
  • BLFS 11-12-2024
  • Dividend Yield
  • BCAX N/A
  • BLFS N/A
  • EPS Growth
  • BCAX N/A
  • BLFS N/A
  • EPS
  • BCAX N/A
  • BLFS N/A
  • Revenue
  • BCAX N/A
  • BLFS $146,957,000.00
  • Revenue This Year
  • BCAX N/A
  • BLFS N/A
  • Revenue Next Year
  • BCAX N/A
  • BLFS N/A
  • P/E Ratio
  • BCAX N/A
  • BLFS N/A
  • Revenue Growth
  • BCAX N/A
  • BLFS 16.40
  • 52 Week Low
  • BCAX $16.29
  • BLFS $14.50
  • 52 Week High
  • BCAX $28.09
  • BLFS $28.88
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • BLFS 58.39
  • Support Level
  • BCAX N/A
  • BLFS $26.06
  • Resistance Level
  • BCAX N/A
  • BLFS $28.35
  • Average True Range (ATR)
  • BCAX 0.00
  • BLFS 1.06
  • MACD
  • BCAX 0.00
  • BLFS 0.01
  • Stochastic Oscillator
  • BCAX 0.00
  • BLFS 65.63

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Share on Social Networks: